Page last updated: 2024-10-22

amiodarone and Encephalopathy, Hepatic

amiodarone has been researched along with Encephalopathy, Hepatic in 5 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research Excerpts

ExcerptRelevanceReference
" During amiodarone infusion a torsade de pointes occurred, which was immediately converted to sinus rhythm by synchronized cardioversion."7.75"Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval. ( Benazzi, B; Bernardi, M; Berzigotti, A; Bracci, E; Di Micoli, A; Trevisani, F; Zambruni, A; Zappoli, P; Zoli, M, 2009)
" During amiodarone infusion a torsade de pointes occurred, which was immediately converted to sinus rhythm by synchronized cardioversion."3.75"Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval. ( Benazzi, B; Bernardi, M; Berzigotti, A; Bracci, E; Di Micoli, A; Trevisani, F; Zambruni, A; Zappoli, P; Zoli, M, 2009)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Waguespack, T1
Cutshall, BT1
Brooks, C1
Di Micoli, A1
Zambruni, A1
Bracci, E1
Benazzi, B1
Zappoli, P1
Berzigotti, A1
Zoli, M1
Bernardi, M1
Trevisani, F1
Iliopoulou, A1
Giannakopoulos, G1
Mayrikakis, M1
Zafiris, E1
Stamatelopoulos, S1
Lwakatare, JM1
Morris-Jones, S1
Knight, EJ1
Yagupsky, P1
Gazala, E1
Sofer, S1
Maor, E1
Abarbanel, J1

Other Studies

5 other studies available for amiodarone and Encephalopathy, Hepatic

ArticleYear
The aftermath of amiodarone therapy: Hyperammonemia and encephalopathy.
    The Nurse practitioner, 2022, 06-01, Volume: 47, Issue:6

    Topics: Amiodarone; Brain Diseases; Hepatic Encephalopathy; Humans; Hyperammonemia

2022
"Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41, Issue:7

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Hepatic Encephalopathy; Human

2009
Reversible fulminant hepatitis following intravenous amiodarone loading. Amiodarone hepatotoxicity.
    International journal of clinical pharmacology and therapeutics, 1999, Volume: 37, Issue:6

    Topics: Aged; Amiodarone; Angina, Unstable; Anti-Arrhythmia Agents; Hepatic Encephalopathy; Humans; Male

1999
Fatal fulminating liver failure possibly related to amiodarone treatment.
    British journal of hospital medicine, 1990, Volume: 44, Issue:1

    Topics: Amiodarone; Atrial Fibrillation; Female; Hepatic Encephalopathy; Humans; Middle Aged

1990
Fatal hepatic failure and encephalopathy associated with amiodarone therapy.
    The Journal of pediatrics, 1985, Volume: 107, Issue:6

    Topics: Amiodarone; Benzofurans; Biopsy; Child; Female; Hepatic Encephalopathy; Humans; Liver; Reye Syndrome

1985